$ANVS Annovis Bio, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Annovis Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Annovis Bio, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Annovis Bio, Inc. for free.
IRS Number: 262540421
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ANVS
Company Address: 1055 WESTLAKES DRIVE, SUITE 300 BERWYN 19312
Phone number: 610-727-3913
Former name: QR Pharma, Inc., date of change: 2009-12-02
Annovis Bio, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | Bruck Claudine | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | White Mark K. | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Jul 06 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | A | 4.39 | 20,000 | 87,800 | 20,000 | |
| Apr 13 2020 | ANVS | Annovis Bio, Inc. | McGroarty Jeffrey Brian | Chief Financial Off ... | Option Exercise | A | 3.13 | 300,000 | 939,000 | 300,000 | |
| Apr 13 2020 | ANVS | Annovis Bio, Inc. | Maccecchini Maria-Luisa | President and CEO | Option Exercise | A | 3.13 | 300,000 | 939,000 | 300,000 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 55,884 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 1,593,118 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 4.80 | 55,884 | 268,243 | 1,400,175 | 1.3 M to 1.4 M (+4.16 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 0.00 | 1,137,942 | 0 | 1,344,291 | 206.3 K to 1.3 M (+551.46 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | C | 0.00 | 158,730 | 0 | 206,349 | 47.6 K to 206.3 K (+333.33 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Buy | P | 6.00 | 33,333 | 199,998 | 47,619 | 14.3 K to 47.6 K (+233.33 %) |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 11,176 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Option Exercise | C | 0.00 | 83,333 | 0 | 0 | |
| Feb 05 2020 | ANVS | Annovis Bio, Inc. | Whelan, Jr. Robert M. | Director | Buy | C | 4.80 | 11,176 | 53,645 | 95,700 | 84.5 K to 95.7 K (+13.22 %) |